Annual Price Revision Could Plunge Pharma Industry into Doldrums: Pfizer Japan Chief

Pfizer Japan President Ichiro Umeda Proposed annual drug price revisions could dip the pharmaceutical industry into the doldrums in the medium to long term, Pfizer Japan President Ichiro Umeda warned at a press reception held on December 2. “We hope...read more